Cinven to buy menopause specialist Theramex in €2.6bn deal

Cinven has agreed to acquire the menopause specialist Theramex from Carlyle Group and PAI Partners for €2.6 billion, marking a significant increase from the price they paid four years ago. This deal highlights the growing investment in women's health and underscores the sector's potential for substantial growth. As women’s health becomes a more prominent focus in global healthcare, such acquisitions signal a strategic shift towards addressing specific health needs and advancing research in this area. For more details, check out the full article on the Financial Times website.